UK to roll out COVID-19 antiviral drug trial this month

By: |
November 07, 2021 4:10 PM

The government said in October it had secured 480,000 courses of the Merck drug, as well as 250,000 courses of an antiviral pill developed by Pfizer Inc.

Covid PositiveHopkins said all the trials so far had been done with the unvaccinated. (File)

Britain will start to roll out Merck’s molnupiravir COVID-19 antiviral pill through a drug trial later this month, Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency said on Sunday.

Last week Britain became the first country in the world to approve the potentially game-changing COVID-19 antiviral pill, jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics.

The government said in October it had secured 480,000 courses of the Merck drug, as well as 250,000 courses of an antiviral pill developed by Pfizer Inc.

Asked about the molnupiravir approval, Hopkins told BBC television: “That is great news and it will start to be rolled out through a drug trial in the end of this month/the beginning of December.”

Hopkins said all the trials so far had been done with the unvaccinated, so this would help understand how it will work in the wider vaccinated population.

“The new Pfizer drug is probably not going to be licensed until the new year some time,” she added. “It is still likely to be a couple of months away.”

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Study suggests past COVID infection may not fend off omicron
2After India confirms Omicron cases, WHO calls for strengthening response measures in South-East Asia
3COVID-19: Delhi records 54 new cases; positivity rate 0.09 pc